Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3MQR65
Thu, 05.12.2024
Viromed Medical AG
Viromed Medical AG: Cooperation between relyon plasma GmbH and Viromed Medical GmbH
Pinneberg/Regensburg, 5 December 2024 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) is pleased to inform about the cooperation between its subsidiary Viromed Medical GmbH and relyon plasma GmbH, a subsidiary of TDK Electronics AG (link to the original news [ … ]
Tue, 03.12.2024
Viromed Medical AG
Viromed Medical AG is expanding its Management Board – Christian Strauch has been appointed as a new member of the Management Board
Pinneberg, 3 December 2024 – The Supervisory Board of Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) has appointed Mr. Christian Strauch as a new member of the company's Management Board with effect [ … ]
Tue, 03.12.2024
Viromed Medical AG
Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights.
Pinneberg, 3 December 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”; the “Company”) plans to acquire all shares in pharmedix GmbH, Hamburg, and thus to expand its po [ … ]
Fri, 29.11.2024
Viromed Medical AG
Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value
Pinneberg, 29 November 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”; the “Company”) has terminated negotiations for the planned acquisition of all shares in ActivCell Group AG, Switzerland, and will [ … ]
Tue, 26.11.2024
Viromed Medical AG
Viromed Medical AG: cold plasma as a digital antibiotic for the lungs
Innovative prevention measure for ventilator-associated pneumonia reaches next stage
Use of cold plasma can prevent tens of thousands of deaths in Germany alone
Study led by expert from the renowned research network BREATH, Hortense Slevogt
Pinneberg, 26 November 2024 – Virom [ … ]
Tue, 17.09.2024
Viromed Medical AG
Viromed Medical AG plans to acquire all shares in ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights
Pinneberg, 17 September 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”; the “Company”) plans to acquire all shares in ActivCell Group AG, Switzerland, and thus s [ … ]
Tue, 17.09.2024
Viromed Medical AG
Viromed Medical AG plans to acquire all shares in ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights
Pinneberg, 17 September 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”; the “Company”) plans to acquire all shares in ActivCell Group AG, Switzerland, and thus s [ … ]
Mon, 02.09.2024
Viromed Medical AG
Viromed Medical AG: Successful start of trading on XETRA
Listing on leading German financial market increases liquidity and expands investor base
Aiming to expand its pioneering role in the medical use of cold plasma technology
Pinneberg, 2 September 2024 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) has reached another mil [ … ]
Wed, 10.07.2024
Viromed Medical AG
Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP)
Targeted use of the antimicrobial effect of cold plasma beyond wound treatment
Use of cold plasma could revolutionize the treatment of VAP and significantly reduce mortality
Aiming for rapid special approval for own devic [ … ]
Fri, 05.07.2024
Viromed Medical AG
Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect
Pinneberg, 5 July 2024 – Viromed Medical GmbH, a wholly owned subsidiary of Viromed Medical AG, and terraplasma medical GmbH have today terminated their business relation with immediate effect.
As part of the previous cooperation [ … ]